Glossary term
503B outsourcing facility
A pharmacy designation for compounded medications prepared in larger batches with stricter regulatory oversight. Also cannot compound BPC-157.
Related Procedures
503B outsourcing facility appears in the following procedure guides on ProcedureFinder:
Peptides
BPC-157 Peptide Therapy
A 15-amino-acid pentadecapeptide derived from a gastric protein, marketed for tendon, ligament, and gut healing. Currently restricted by FDA from 503A compounding.
Weight Loss
Semaglutide for Weight Loss
Weekly GLP-1 receptor agonist injection that reduces appetite and food cravings, typically producing 12 to 17 percent body weight loss over 12 months.
Weight Loss
Tirzepatide for Weight Loss
Weekly dual GIP/GLP-1 agonist injection delivering 18 to 22 percent body weight loss in 72 weeks, slightly outperforming semaglutide in head-to-head trials.